Indraprastha Medical Corporation Ltd Share Price Today - Indraprastha Medical Corporation Ltd Stock Price Live NSE/BSE

Indraprastha Medical Corporation Ltd

NSE: INDRAMEDCO BSE: 532150

₹396.25

(1.42%)

Thu, 26 Mar 2026, 02:56 pm

MTF 5xInvest in Indraprastha Medical Corporation Ltd with 5x Leverage Buy with MTF

Market Cap36.25B

PE Ratio19.86

Dividend1.14

Health Services

Hospital/Nursing Management

24.5K

Indraprastha Medical Corporation Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
3710.01
Net Profit
160.99
P/B
5.93
Sector P/E
71.94
P/E
21.98
EV/EBITDA
12.18
Debt/Equity (Industry)
0.48
Interest Cover (Industry)
7.37
ROCE (Industry)
16.81
RONW (Industry)
18.56
ROE
29.97
ROCE
37.11
Debt/Equity
0.06
EPS (TTM)
19.95
Dividend Yield
1.11
Book Value
71.82
Interest Cover
35.50

Analysis

all

Pros

Indraprastha Medical is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Indraprastha Medical is profitable, therefore cash runway is not a concern.
Indraprastha Medical is profitable, therefore cash runway is not a concern.
Debt is well covered by operating cash flow (2174.9%, greater than 20% of total debt).
Debt is covered by short term assets, assets are 35.6x debt.

Cons

Unable to calculate sustainability of dividends as Indraprastha Medical has not reported any payouts.
Unable to evaluate Indraprastha Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Indraprastha Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.
High level of physical assets or inventory.
Indraprastha Medical is not covered by any analysts.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	51.00	51.00	51.00	51.00	51.00
FII	2.73	2.41	2.72	2.94	2.88
DII	0.83	3.51	3.56	3.56	3.19
Public	45.44	43.08	42.72	42.51	42.93
Government	0	0	0	0	0

Technical Analysis

RSI

52.66

MACD

-2.83

50 DMA

394.30

200 DMA

461.39

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	566.18	482.48	442.27	398.78	358.57	315.08	231.38
Fibonacci	482.48	450.51	430.76	398.78	366.81	347.06	315.08
Camarilla	425.07	417.39	409.72	398.78	394.38	386.71	379.03

Pivots Level: Classic

+167.40

566.18

+83.70

482.48

+43.48

442.27

398.78

Pivot Point

LTP: 405.15

-40.22

358.57

-83.70

315.08

-167.40

231.38

Moving Average

SMAEMA

Period

Value

10-EMA
394.04
20-EMA
395.88
30-EMA
398.34
50-EMA
406.77
100-EMA
427.76
200-EMA
438.93

Announcement Date	Purpose	Action	Ex Date
03 Feb 2026	board-meetings	Quarterly Results, Nine Months Results
01 Nov 2025	board-meetings	Quarterly Results
18 Aug 2025	dividend	Final Dividend - Rs. - 4.5	18 Sept 2025
06 Aug 2025	agm
15 May 2025	dividend	₹4.50 Dividend /Share	18 Sept 2025
13 Aug 2024	dividend	Annual General Meeting/Dividend - Rs 4.50 Per Share	14 Sept 2024
05 Aug 2024	agm
17 May 2024	dividend	₹4.50 Dividend /Share	14 Sept 2024
15 Aug 2023	dividend	Annual General Meeting/Dividend - Rs 3 Per Share	16 Sept 2023
04 Aug 2023	agm

Indraprastha Medical Corporation Ltd

Aster DM Healthcare Ltd

Narayana Hrudayalaya Ltd

Max Healthcare Institute Ltd

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd

Indraprastha Medical Corporation Ltd About

Indraprastha Medical Corporation s a super specialty hospital commissioned in December 1995 in collaboration with the New Delhi administration. The hospital houses over 50 medical specialties including multi-organ transplants, non-invasive neuro-surgeries and day care procedures.

Industry

Healthcare

Founded

1988

Headquarters

CEO

Prathap C Reddy

Employees

Contact

Website

https://www.delhi.apollohospitals.com

Priya_r@apollohospitalsdelhi.com

Phone

91-11-26925858/26925801

Location

Sarita Vihar, Delhi-Mathura Road, New Delhi, New Delhi, 110076

Year	History
2010	Indraprastha Medical Corporation Ltd has recommended the payment of dividend @ 16% i.e. Rs. 1.60per share.
2011	Indraprastha Medical Corporation Ltd as a part of the expansion plan undertaken by the Company, 50 additional beds have been commissioned in the Hospital. Indraprastha Medical has recommended the payment of dividend @ 16% i.e. Rs. 1.60 per share
2012	Indraprastha Medical has recommended the payment of dividend @ 16% i.e. Rs. 1.60 per share
2013	Indraprastha Medical Corporation Ltd has recommended the payment of dividend @ 16% i.e.Rs. 1.60 per share. Indraprastha Medical Corporation Ltd have appointed Ms. Archana Arora Principal Secretary (Finance / Planning), Govt. of NCT of Delhi as an Additional Director of the Company.
2014	Indraprastha Medical Corporation Ltd has recommended a dividend @ 18% (Rs. 1.80 per share). Indraprastha Medical Corporation Ltd have appointed Mr. D. M. Spolia - Chief Secretary, Govt. of NCT of Delhi, as an Additional Director and Chairman of the Board of Directors of the Company. Indraprastha Medical Corporation Ltd have appointed Ms. Vineeta Rai as an Additional Director of the Company.

Client Name	Order Side	QTY	Avg Price	Date
GRAVITON RESEARCH CAPITAL LLP	Sell	1232350	586.98	08 Oct 2025
GRAVITON RESEARCH CAPITAL LLP	Buy	1232834	587.07	08 Oct 2025
SWAY FINANCIAL SERVICES	Buy	487634	555.26	07 Oct 2025
SWAY FINANCIAL SERVICES	Sell	9294	512.53	07 Oct 2025
GRAVITON RESEARCH CAPITAL LLP	Sell	541765	327.42	07 Aug 2024
GRAVITON RESEARCH CAPITAL LLP	Buy	541765	327.06	07 Aug 2024
QUANT MUTUAL FUND - QUANT SMALL CAP FUND	Buy	550000	249.59	22 Apr 2024
GRAVITON RESEARCH CAPITAL LLP	Buy	707868	99.69	09 Jun 2021
GRAVITON RESEARCH CAPITAL LLP	Sell	707868	99.69	09 Jun 2021
GRAVITON RESEARCH CAPITAL LLP	Sell	483819	97	07 Jun 2021

Indraprastha Medical Corporation Ltd News

Indraprastha Medical Corporation Shareholders Approve Board Changes

Indraprastha Medical Corporation Limited successfully concluded postal ballot voting on 20th March, 2026, with shareholders approving all four special resolutions for independent director appointments and re-appointments with requisite majority.

21 Mar 2026

companies

Indraprastha Medical seeks postal ballot approval

Indraprastha Medical Corporation Limited announces postal ballot for re-appointment of three Independent Directors and appointment of one new Independent Director, with e-voting from February 19 to March 20, 2026.

18 Feb 2026

stocks

Indraprastha Medical Corporation Q3FY26 Results

Indraprastha Medical Corporation reported Q3FY26 revenue of ₹378.76 crore and net profit of ₹41.00 crore. Nine-month revenue reached ₹1159.12 crore with net profit of ₹141.92 crore.

04 Feb 2026

co actions results

Indraprastha Medical Corp Reports Revenue Growth to Rs 3.8B in Q2

Indraprastha Medical Corp reported Q2 revenue of Rs 3.8 billion, up from Rs 3.5 billion in the same quarter last year. The company's EBITDA increased to Rs 713 million from Rs 636 million year-over-year. EBITDA margin improved to 18.72% compared to 18.19% in the previous year's corresponding quarter.

01 Nov 2025

earnings

Indraprastha Medical Corp Reports 16.6% Growth in Net Profit

Indraprastha Medical Corp reported a net profit of Rs 494.6 million for Q2, compared to Rs 424 million in the same period last year, representing a year-on-year increase of 16.6%.

01 Nov 2025

earnings

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800